Literature DB >> 15450791

Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults.

Audrey R Tyrka1, Linda L Carpenter, Christopher J McDougle, Paul D Kirwin, Michael J Owens, Charles B Nemeroff, David R Strong, Lawrence H Price.   

Abstract

BACKGROUND: Brain serotonin neurotransmission and hypothalamic-pituitary-adrenal axis function are implicated in the pathophysiology of depression, and these systems interact in a reciprocal modulatory fashion. This study examined the effect of tryptophan depletion, which acutely reduces brain serotonin concentrations, on serial cerebrospinal fluid concentrations of corticotropin-releasing factor in healthy humans.
METHODS: Five subjects completed a standard tryptophan depletion protocol, and four subjects participated in a comparison condition. Subjects underwent continuous sampling of cerebrospinal fluid via lumbar peristaltic pump. Concentrations of cerebrospinal fluid corticotropin-releasing factor were measured by radioimmunoassay.
RESULTS: No mood changes were observed in either group. Tryptophan-depleted subjects exhibited significantly greater increases in corticotropin-releasing factor concentrations over time than subjects in the comparison condition.
CONCLUSIONS: These findings highlight the potential importance of corticotropin-releasing factor and serotonin interactions and suggest that activation of corticotropin-releasing-factor-containing neurons could play a role in the emergence of mood symptoms following tryptophan depletion in vulnerable individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450791     DOI: 10.1016/j.biopsych.2004.06.035

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.

Authors:  Francisco A Moreno; Damian Parkinson; Craig Palmer; Wm Lesley Castro; John Misiaszek; Aram El Khoury; Aleksander A Mathé; Ron Wright; Pedro L Delgado
Journal:  Eur Neuropsychopharmacol       Date:  2010-01       Impact factor: 4.600

2.  Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.

Authors:  Christian Grillon; Chanen Chavis; Matthew F Covington; Daniel S Pine
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

Review 3.  Gene-environment interactions: early life stress and risk for depressive and anxiety disorders.

Authors:  Nicole R Nugent; Audrey R Tyrka; Linda L Carpenter; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2011-01-12       Impact factor: 4.530

4.  Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women.

Authors:  J S Labus; E A Mayer; J Jarcho; L A Kilpatrick; T O C Kilkens; E A T Evers; W H Backes; R-J M Brummer; M A van Nieuwenhoven
Journal:  Gut       Date:  2011-03-14       Impact factor: 23.059

Review 5.  Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models.

Authors:  John H Kehne; Christopher K Cain
Journal:  Pharmacol Ther       Date:  2010-09-06       Impact factor: 12.310

6.  Acute tryptophan depletion increases translational indices of anxiety but not fear: serotonergic modulation of the bed nucleus of the stria terminalis?

Authors:  Oliver J Robinson; Cassie Overstreet; Phillip S Allen; Daniel S Pine; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2012-04-11       Impact factor: 7.853

7.  Early-life stress, corticotropin-releasing factor, and serotonin transporter gene: a pilot study.

Authors:  Jeremy D Coplan; Chadi G Abdallah; Joan Kaufman; Joel Gelernter; Eric L P Smith; Tarique D Perera; Andrew J Dwork; Arie Kaffman; Jack M Gorman; Leonard A Rosenblum; Michael J Owens; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2010-08-06       Impact factor: 4.905

Review 8.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 9.  Childhood trauma and personality disorder: toward a biological model.

Authors:  Royce Lee
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

Review 10.  Future prospects in depression research.

Authors:  Paul E Holtzheimer; Charles B Nemeroff
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.